| Preferred name | (1R,2S)-(-)-ephedrine hydrochloride |
| Trivial Name | (-)-Ephedrine hydrochloride |
| Short Description | (1R,2S)-2-(methylamino)-1-phenyl-1-propanol hydrochloride (1:1) |
| Formula | C10 H16 Cl N O |
| CAS Number | 50-98-6 |
| Deleted CAS Number | 14992-57-5 |
| ECHA Number | 200-074-6 |
| FDA UNII | NLJ6390P1Z |
| Beilstein Number | 3630391 |
| MDL | MFCD00066127 |
| Bio Activity Summary | External link |
| NMR Predictor | External link |
| Synonyms |
|
| Google Scholar | Start search |
| Google Books | Start search |
| Google Patents | Start search |
| Perfumer & Flavorists | Start search |
| EU Patents | Start search |
| PubMeb | Start search |
| NCBI | Start search |
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| CHEMBL: | View |
| KEGG (GenomeNet): | D01386 |
| HMDB (The Human Metabolome Database): | Search |
| Export Tariff Code: | 2939.40.5000 |
| ChemSpider: | View |
| Wikipedia: | View |
| Material listed in food chemical codex | No |
| Molecular weight | 201.6957244873 |
| Vapor Pressure | 0.00865 mmHg @ 25 °C |
| Flash Point TCC Value | 85.6 °C TCC |
| logP (o/w) | 1.054 est |
| Solubility | |
| water, 2.50E+05 mg/L @ 25 °C (exp) | Yes |
| water, 1e+006 mg/L @ 25 °C (est) | Yes |
| Preferred SDS: View | |
| Hazards identification | |
| Classification of the substance or mixture | |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) | |
| None found. | |
| GHS Label elements, including precautionary statements | |
| Pictogram | |
| Hazard statement(s) | |
| None found. | |
| Precautionary statement(s) | |
| None found. | |
| Oral/Parenteral Toxicity: | |
| intravenous-cat LDLo 60 mg/kg CARDIAC: OTHER CHANGES Medecine Vol. 9, Pg. 59, 1930. intravenous-dog LDLo 70 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Medecine Vol. 9, Pg. 59, 1930. parenteral-frog LDLo 440 mg/kg Manshu Igaku Zasshi. Manchuria Medical Journal. Vol. 3, Pg. 1, 1925. intravenous-guinea pig LD50 98 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: EXCITEMENT Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 59, Pg. 355, 1963. intraperitoneal-hamster LDLo 350 mg/kg CARDIAC: OTHER CHANGES Medecine Vol. 9, Pg. 59, 1930. intraperitoneal-mouse LD50 242 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 158, Pg. 135, 1967. intravenous-mouse LD50 95 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 336, 1949. oral-mouse LD50 400 mg/kg Journal of Medicinal Chemistry. Vol. 9, Pg. 966, 1966. parenteral-mouse LDLo 500 mg/kg Manshu Igaku Zasshi. Manchuria Medical Journal. Vol. 3, Pg. 1, 1925. intramuscular-rabbit LD50 175 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. intravenous-rabbit LD50 65 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 336, 1949. intraperitoneal-rat LD50 165 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. intravenous-rat LD50 69 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 33, Pg. 80, 1944. | |
| Dermal Toxicity: | |
| subcutaneous-dog LDLo 220 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Medecine Vol. 9, Pg. 59, 1930. subcutaneous-frog LDLo 400 mg/kg LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE Medecine Vol. 9, Pg. 59, 1930. subcutaneous-guinea pig LD50 192 mg/kg PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE BEHAVIORAL: EXCITEMENT Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 59, Pg. 355, 1963. subcutaneous-mouse LD50 40870 ug/kg BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: EXCITEMENT Journal of Pharmacology and Experimental Therapeutics. Vol. 87, Pg. 214, 1946. subcutaneous-rabbit LD50 165 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 86, Pg. 284, 1946. subcutaneous-rat LD50 1150 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 95, Pg. 336, 1949. | |
| Inhalation Toxicity: | |
| Not determined | |
| Category: | |||
| pharmaceuticals / chemical synthisis | |||
| Recommendation for (1R,2S)-(-)-ephedrine hydrochloride usage levels up to: | |||
| not for fragrance use. | |||
| Recommendation for (1R,2S)-(-)-ephedrine hydrochloride flavor usage levels up to: | |||
| not for flavor use. | |||
| EPI System: View |
| ClinicalTrials.gov:search |
| Daily Med:search |
| AIDS Citations:Search |
| Cancer Citations:Search |
| Toxicology Citations:Search |
| EPA Substance Registry Services (TSCA):50-98-6 |
| EPA ACToR:Toxicology Data |
| EPA Substance Registry Services (SRS):Registry |
| Laboratory Chemical Safety Summary :65326 |
| National Institute of Allergy and Infectious Diseases:Data |
| WGK Germany:1 |
| (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride |
| Chemidplus:0000050986 |
| RTECS:KB1750000 for cas# 50-98-6 |